FDA Adverse Event Injury Summary report: N

UNKNOWN ENDO GIA SULU

MDR report key: 23255798 · Received October 9, 2025

Report

Report Number
1219930-2025-04581
Event Type
Injury
Date Received
October 9, 2025
Date of Event
July 15, 2025
Report Date
October 9, 2025
Manufacturer
COVIDIEN SURGICAL
Product Code
GDW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

TRIEMSTRA L, DE JONGH C, BRENKMAN HJF, WEUSTEN BLAM, FREUND JE, HILLEGERSBERG RV, RUURDA JP. IMPLEMENTING ROBOT-ASSISTED MINIMALLY I NVASIVE GASTRECTOMY (RAMIG) FOR GASTRIC CANCER IN A EUROPEAN TERTIARY REFERRAL CENTER. EUR J SURG ONCOL. 2025 JUL 16;51(10):110342. DOI: 10.1016/J.EJSO.2025.110342. EPUB AHEAD OF PRINT. PMID: 40780020. D.10. CONCOMITANT PRODUCTS: UNKNOWN EEA, UNKNOWN EEA, (LOT # UNKNOWN); UNKNOWN EEA, UNKNOWN EEA, (LOT # UNKNOWN); UNKNOWN-VLOC, UNKNOWN VLOC PRODUCT, (LOT # UNKNOWN); UNKNOWN-VLOC, UNKNOWN VLOC PRODUCT, (LOT # UNKNOWN); UNKNOWN EEA, UNKNOWN EEA, (LOT # UNKNOWN); UNKNOWN EEA, UNKNOWN EEA, (LOT # UNKNOWN). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

ACCORDING TO THE LITERATURE, A PROSPECTIVE STUDY COMPARED 111 PATIENTS WHO UNDERWENT MINIMALLY INVASIVE GASTRECTOMY (MIG) WITH 75 PATIENTS WHO UNDERWENT ROBOT-ASSISTED MINIMALLY INVASIVE GASTRECTOMY (RAMIG) BETWEEN 2007 AND 2023. IN THE MIG GROUP AND 31 PATIENTS IN THE RAMIG GROUP, A CIRCULAR STAPLER WITH AN ORAL ANVIL WAS USED TO CREATE THE ESOPHAGOJEJUNOSTOMY. IN THE REMAINING RAMIG PATIENTS, A BARBED SUTURE WAS USED TO PERFORM THE ESOPHAGOJEJUNOSTOMY. THE JEJUNOJEJUNOSTOMY WAS EITHER LINEAR STAPLED OR HANDSEWN WITH ANOTHER KIND OF BARBED SUTURE. THE DUODENAL TRANSECTION WAS PERFORMED USING AN ENDOSCOPIC LINEAR STAPLER. COMPLICATIONS INCLUDE ANASTOMOTIC AND DUODENAL STUMP LEAK. TREATMENT OF ESOPHAGOJEJUNOSTOMY LEAKS INCLUDED ENDOSCOPIC TREATMENT, REOPERATION, OR ANTIBIOTICS. DUODENAL STUMP LEAKS REQUIRED ANTIBIOTICS AND JEJUNOJEJUNOSTOMY LEAKS REQUIRED SURGICAL INTERVENTION. INTENSIVE CARE UNIT ADMISSION AND PROLONGED HOSPITALIZATION WERE REPORTED. OTHER COMPLICATIONS NOT RELATED TO THE DEVICE INCLUDED INTRAOPERATIVE BLEEDING AND ORGAN INJURY, CHYLE LEAK AND PNEUMONIA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2610741 UNKNOWN ENDO GIA SULU STAPLE, IMPLANTABLE GDW COVIDIEN SURGICAL NKNOWN ENDO GIA SULU

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Hospitalization| R| O SEE H11